Global Health
Global health continues to face immense challenges from infectious diseases and inadequate diagnostic and therapeutic systems. Major gaps remain in our ability to develop effective vaccines and treatments, rapidly diagnose diseases, and prevent pathogen transmission. Addressing these issues is essential to reduce global morbidity and mortality, especially in low-resource settings, and ensure a resilient, interconnected world.
R&D Gaps (3)
Many of the world’s most deadly diseases—such as tuberculosis, Group A Streptococcus, hepatitis C, hepatitis B, and syphilis—lack effective vaccines or cures. Additionally, the pace of developing effective, low-cost, therapeutics for emerging pathogens in low resource settings is too slow to meet gl...
Current diagnostic tests are costly or often offer only limited information, failing to reveal the cause of disease and delaying or preventing administration of available treatments. Moreover, early detection systems for emerging pathogens are fragmented, delaying critical public health intervention...
Global health outcomes are compromised by insufficient health systems and infrastructure that limit our ability to prevent and control infectious diseases. Key deficiencies include the lack of cost-effective antimicrobial materials to block pathogen transmission, underdeveloped intervention models f...